Landau Lab
Cancer Genomics & Evolutionary Dynamics at WCM/NYGC
Xiaoli Mi receives the Damon Runyon Physician-Scientist Training Award! 3/20/2024
Landau lab receives award for the NIH Common Fund's Somatic Mutation across Human Tissue (SMaHT) Network with the Satija lab! 5/11/2023
Dan Landau receives an Established Investigator Award from the Melanoma Research Alliance! 5/1/2023
Adam Widman receives a Young Investigator Award from the Melanoma Research Alliance! 5/1/2023
Xiaoli Mi receives the American Society of Hematology Research Training Award for Fellows! 4/21/2023
Congratulations to Landau lab members Dr. Adam Widman and Dr. Franco Izzo, winners of the New York Genome Center's Recognition Awards 2022 12/9/2022
Adam Widman, Innovation and Discovery Award
Franco Izzo, Innovation and Discovery Award
Dr. Franco Izzo
Weill Cornell Medicine Impact Feature covering the lab's work on single-cell mutiomics and cancer evolution 11/14/2022
Dan Landau participates in a panel about Machine Learning in Oncology at the Cancer Summit 04/24/2022
Dan Landau receives the Mark Foundation Emerging Leader award
01/05/2022
08/20/2021
C2i Genomics, Landau lab start up is selected as a finalist for the 2021 Nature Spinoff Prize!
06/24/2021
Dan Landau receives the Jeanne and Herbert Siegel WCM Faculty Development Award
05/15/2021
Neville Dusaj receives the F30 NCI Award!
02/15/2021
Our cfDNA work selected as top 10 Clinical Research Achievement by the Clinical Research Forum
01/27/2021
Franco Izzo receives the ASH Fellow to Faculty Award!
01/13/2021
Dan Landau receives the Sontag Foundation Distinguished Scientist Award
10/13/2020
Anna Nam receives the NIH Director's Early Independence Award and starts her own lab!
09/20/2020
Landau lab is awarded NHGRI Center of Excellence in Genomic Science award with Satija and Smibert labs at NYGC!
08/13/2020
Dan Landau receives the Vallee Scholar Award
10/13/2020
Anna Nam receives the Career Award for Medical Scientists from Burroughs Wellcome Fund!
05/20/2020
Adam Widman receives a Young Investigator Award from ASCO!
05/25/2020
Federico Gaiti receives a K99 award from the NCI!
04/30/2020
Landau lab receives an award from CZI together with a team led by Giannerelli lab (MSSM) to develop single-cell methods to study inflammation
Dan Landau receives the Leukemia Lymphoma Society Scholar Award
02/01/2020
Federico Gaiti receives the Lymphoma Research Foundation award!
04/03/2020
Dan Landau is selected as a member of the American Society of Clinical Investigation
04/01/2020
Anna Nam receives K08 from NHLBI!
03/27/2020
Federico Gaiti selected as Leukemia Lymphoma Society Fellow!
02/01/2020
Anna Nam selected as Leukemia Lymphoma Society Special Fellow!
02/01/2020
Landau lab receives an ASPIRE award from the Mark Foundation to develop liquid biopsy methods for pre-invasive lesions
01/27/2019
Landau lab in collaboration with the Kharas lab (MSKCC) receives funding from Tri-Institutional's Stem Cell Initiative Award to develop novel single-cell methods to study hematopoietic stem cell fate decisions.
01/23/2019
Federico Gaiti receives the American Society of Hematology Scholar award!
12/20/2019
11/26/2019
Dan Landau receives the 2019, Weill Cornell Department of Medicine Young Investigators Award
06/27/2019
Danny Luan receives the 2019 ASH HONORS award
06/20/2019
Asaf Zviran receives the 2018 NYGC Innovation Award for his liquid biopsy work
12/7/2018
Nathan Omans Selected as a NYSTEM Stem Cell Biology Scholar
11/1/2018
The Landau lab receives the Lung Cancer Discovery Award from the American Lung Association
07/10/2018
03/28/2018
Dan Landau receives the 2017 American Society of Hematology Joanne Levy, MD, Memorial Award for Outstanding Achievement
12/02/2017
Dan Landau receives the 2018 Pershing Square Sohn Prize for Young Investigators in Cancer Research
05/22/2018
Franco Izzo awarded the American Society of Hematology Outstanding Achievement Abstract Award for submitting the top-scoring abstract of the 2017 annual meeting
12/02/2017
Dan Landau selected for HemOnc Today’s Next Gen Innovators
11/30/2017
Columbia University Physical Sciences in Oncology Center pilot grant awarded in collaboration with the Rabadan lab (CU) for novel multi-omics single cell technology development
07/20/2017
11/04/2016
This award will fund the development of novel epigenetic single-cell and editing technology
11/16/2016
The Landau lab receives prestigious Broad Next 10 Catalytic Steps funding
12/20/2015
The Broad Institute will provide 500,000$ in funding over the next year to develop "Modeling Cancer Diversity and Evolution for Precision Combination Cancer Therapeutics". This ambitious project will be carried out jointly with Cory Johannessen at the Broad Institute, to identify novel ways to overcome lung cancer evolution and resistance to therapy.
The Landau Lab receives an Innovative Research Grant from the Stand Up To Cancer foundation.
04/18/2016
Dan Landau receives the 2016 Kimmel Scholar Award by the Sydney Kimmel Foundation.
04/12/2016
The Kimmel Scholar award will fund a project titled: "Knowledge infrastructure for data-driven combination leukemia therapy engineering."
04/12/2016
Dan Landau receives the 2016 Young Physician-Scientist Award by the American Society of Clinical Investigation
03/01/2016
To be presented in April at the AAP-ASPA-ASCI joint annual meeting in Chicago.
The Landau Lab receives the Leukemia Lymphoma Society Translational Research Program Award.
06/29/2016
This award will fund the development of dynamic therapeutic optimization based on liquid biopsy technology
The Landau Lab receives a 200K$ award from the Meyer Cancer Center Liquid Biopsy Initiative
10/10/2016
This award will fund the development of new liquid biopsy technology for early cancer detection
Quantitative Clonal Dynamics Define Mechanisms of CLL Evolution in Response to Combination Chemotherapy – selected for Best of ASH
12/06/2015
Dense temporal sampling of leukemia samples from patients treated with chemoimmunotherapy enabled the study of evolutionary kinetics directly in patients. These data describe innovative methodologies to measure clone-specific growth rates with differing therapeutic contexts. The project lays the foundations for algorithmycally-driven therapy based on real-time monitoring of clonal growth. The results were presented at the annual meeting of the American Society of Hematology (ASH) and selected for the Best of ASH presentation.